|
Pineda J, Marín F, Marco P, Roldán V, Valencia J, Ruiz-Nodar JM, Romero DH, Sogorb F, Lip GY. The prognostic value of biomarkers after a premature myocardial infarction. Int J Cardiol. 2010 Sep 3;143(3):249-54. doi: 10.1016/j.ijcard.2009.02.019. Epub 2009 Mar 17. PubMed PMID: 19278741.
AÑO: 2010; IF: 6.802
|
19278741
|
Hernández-Romero D, Marín F, Lee KW, Roldán V, Caturla J, Corral J, Valdés M, Lip GY, Vicente V, González-Conejero R. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction. Thromb Haemost. 2010 Sep;104(3):650-2. doi: 10.1160/TH10-01-0022. Epub 2010 Jun 29. PubMed PMID: 20589311.
AÑO: 2010; IF: 4.701
|
|
Hernández-Romero D, Ruiz-Nodar JM, Marín F, Tello-Montoliu A, Roldán V, Mainar L, Pérez-Andreu V, Antón AI, Bonaque JC, Valdés M, Vicente V, González-Conejero R. CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis. Ann Med. 2010 Sep;42(6):439-46. doi: 10.3109/07853890.2010.499131. PubMed PMID: 20673165.
AÑO: 2010; IF: 4.323
|
|
Cambronero F, Marín F, Roldán V, Hernández-Romero D, Valdés M, Lip GY. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. Eur Heart J. 2009 Jan;30(2):139-51. doi: 10.1093/eurheartj/ehn538. Epub 2009 Jan 9. Review. PubMed PMID: 19136482.
AÑO: 2009; IF: 9.8
|
|
Saura D, Marín F, Climent V, González J, Roldán V, Hernández-Romero D, Oliva MJ, Sabater M, de la Morena G, Lip GY, Valdés M. Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling. Int J Clin Pract. 2009 Oct;63(10):1465-71. doi: 10.1111/j.1742-1241.2009.02127.x. PubMed PMID: 19769703.
AÑO: 2009; IF: 2.245
|